Biopharma Layoff Tracker 2024. Ongoing restructuring throughout the year,. Protein isolation, identification and characterization.
More recently, two months after acquiring san diego biotech mirati therapeutics in january 2024, in a deal worth $4.8 billion, bristol myers squibb said in a worker adjustment. There are signs of recovery, as mergers and acquisitions picked up across the pharmaceutical and life sciences industry in the latter part of 2023 and have continued their.